Liquid Dosage
Antibiotics, compounds or substances that combat bacterial infections and kill or slow down their growth, comprise one of the most important groups of drugs in the fight against infectious diseases. Representing around 13% of total pharmaceutical consumption, they have the highest market share of any pharmaceutical product.
In liquid-based applications, the pharmaceutical industry extracts antibiotics from fermentation broths. GEA supports this process with special decanters that facilitate the process, offering efficient direct extraction solutions that are also environmentally friendly.
Extraction essentially consists of two combined processes: mixing and separating. GEA has developed a patented decanter that combines the two process steps in a single machine to enhance the extraction of active ingredients.
This decanter allows suspensions with a high solids content to be processed, rendering them suitable for direct antibiotic extraction from the culture solution (which often has a high mycelium content). The previously essential filtration step is no longer required, which not only makes the process continuous, it also prevents the loss of valuable material that was frequently associated with filtration.
Offering increased total yields of up to 98% compared with conventional counter-current extraction, direct extraction is also significantly more cost-effective (no filter aids are needed). The fermentation broth itself is not diluted by filter wash water, which both reduces the solvent requirement and the risk of infection. In addition, the optimized procedure also reduces wastewater pollution and the actual volume of wastewater produced.
Driven by new product innovations, high levels of R&D investment and the pharmaceutical industry’s need to ameliorate the issue of antibiotic resistance, the antibiotic market is expected to show continued growth. From R&D-scale and standalone manufacturing equipment to completely integrated process lines that maximize operational reliability, GEA supplies a complete range of equipment and solutions for the industrial-scale production of antibiotics, antibacterials and anti-infectives.
Affichage de 4 sur 38
Les têtes de compression de GEA constituent le cœur des homogénéisateurs, car elles activent le processus d'homogénéisation en pompant le produit à haute pression jusqu'à ce qu'il s'écoule dans la vanne d'homogénéisation.
Il existe deux versions des séparateurs à disque avec bol à paroi pleine : les séparateurs utilisés pour séparer deux liquides mutuellement insolubles et les clarificateurs utilisés pour séparer les solides des liquides. Toutes les fonctions sont semblables à la fonction des clarificateurs et séparateurs avec bol autonettoyant.
Le séparateur centrifuge de clarification est utilisé pour séparer les solides contenus dans un liquide. Le séparateur est équipé d'une colonne de disques coniques qui créent une grande zone de clarification équivalente dans une chambre de taille relativement petite.
Associer la surveillance du procédé grâce à des analyseurs en ligne aux principes d'ingénierie de procédé et aux techniques avancées de modélisation du procédé permet de contrôler activement le procédé et de pouvoir compenser les variations de l'alimentation.
To support community engagement, GEA offers employees one day of paid time off per year.
How do you lead a dairy farm into the next generation while ensuring a sustainable future and animal welfare while managing increasing complexity? This is a question almost every dairy farmer around the world must consider. The...
After reaching its Mission 26 targets two years early, GEA launches Mission 2030 strategy with focus on growth, value and making a positive impact.